These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29171501)

  • 21. [Protective effect of ARB on vascular diseases].
    Kim-Mitsuyama S
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():475-81. PubMed ID: 16895216
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pleiotropic effects of therapy in endothelial dysfunction syndrome].
    Macovei L
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):17-22. PubMed ID: 15688750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical trials of renin-angiotensin antagonists in Japan].
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):182-3. PubMed ID: 18421845
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R
    Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant therapy in diabetic complications: what is new?
    Da Ros R; Assaloni R; Ceriello A
    Curr Vasc Pharmacol; 2004 Oct; 2(4):335-41. PubMed ID: 15320813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction: potential clinical implications.
    Tousoulis D; Koutsogiannis M; Papageorgiou N; Siasos G; Antoniades C; Tsiamis E; Stefanadis C
    Minerva Med; 2010 Aug; 101(4):271-84. PubMed ID: 21030938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.
    Thomas SR; Witting PK; Drummond GR
    Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nitrous oxide and atherosclerosis. Pharmacotherapy of atherosclerosis and nitrous oxide].
    Markov KhM
    Kardiologiia; 2010; 50(12):69-77. PubMed ID: 21591396
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of endothelial dysfunction in atherosclerosis.
    Davignon J; Ganz P
    Circulation; 2004 Jun; 109(23 Suppl 1):III27-32. PubMed ID: 15198963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endothelium and nitric oxide].
    Garaliene V
    Medicina (Kaunas); 2008; 44(7):564-9. PubMed ID: 18695354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
    Schmieder RE
    J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nephrology 2009].
    Zidek W
    Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1316-8. PubMed ID: 19517322
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging therapies for cerebrovascular disorders.
    Fisher M; Davalos A
    Stroke; 2004 Feb; 35(2):367-9. PubMed ID: 14757882
    [No Abstract]   [Full Text] [Related]  

  • 37. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.
    Ceriello A
    Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
    Fischer T
    Orv Hetil; 2015 Nov; 156(46):1847-58. PubMed ID: 26548469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.